Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I van Leuven

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|November 25, 2017
[Spondylodiscitis as a rare manifestation of gout]G F Snijders, L G Schipper, M G Masteling-Slaats, et al.
Lupus|April 26, 2006
Atherogenesis in rheumatologyS I van Leuven, J J P Kastelein, D P D'Cruz, et al.
Rheumatology (Oxford, England)|August 19, 2007
Systemic inflammation as a risk factor for atherothrombosisS I van Leuven, R Franssen, J J Kastelein, et al.
Annals of the Rheumatic Diseases|August 30, 2008
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritisC A Wijbrandts, S I van Leuven, H D Boom, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humansS I van Leuven, R S Birjmohun, R Franssen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|November 25, 2017
[Spondylodiscitis as a rare manifestation of gout]G F Snijders, L G Schipper, M G Masteling-Slaats, et al.
Lupus|April 26, 2006
Atherogenesis in rheumatologyS I van Leuven, J J P Kastelein, D P D'Cruz, et al.
Rheumatology (Oxford, England)|August 19, 2007
Systemic inflammation as a risk factor for atherothrombosisS I van Leuven, R Franssen, J J Kastelein, et al.
Annals of the Rheumatic Diseases|August 30, 2008
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritisC A Wijbrandts, S I van Leuven, H D Boom, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humansS I van Leuven, R S Birjmohun, R Franssen, et al.
Pageof 1